Medtronic reported a slight earnings beat and revenue growth, with analysts giving mixed ratings.
Medtronic plc, a major medical technology firm, saw various institutional investors adjust their stock holdings last year. The company reported Q4 earnings of $1.26 per share, slightly beating expectations, with a 5.2% increase in revenue to $8.4 billion. Medtronic also declared a quarterly dividend of $0.70 per share. Analysts' ratings range from "hold" to "overweight," with an average target price of $95.00.
2 months ago
7 Articles
Articles
Further Reading
You have 4 free stories remaining this month. Subscribe anytime for unlimited access.